Medical Assisted Weightloss
Compounded Semaglutide and Tirzepatide
Semaglutide and Tirzepatide are GLP-1 medications that are injected weekly into a subcutaneous (fatty) area to aid in weightloss. Semaglutide clinical trials shows that on average weight loss of 9% to 12% while Tirzepatide clinical trials shows that on average weight loss of 15% to 21%.
Start Your Journey To A Healthier You
Whether you're seeking relief from Hypertension and/or diabetes, lack confidence or motivation at current weight or simply looking to meet a weightloss goal, our team of experts will join your journey to a more healthier you.
Get started by contacting our team today and learning more about how we can help.
